- Home
- MRNA vs STE Comparison
MRNA vs STE Comparison
Compare MRNA & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | STE |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 22.1B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MRNA | STE |
|---|---|---|
| Price | $48.37 | $213.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 5 |
| Target Price | $34.27 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 7.0M | 697.7K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | 21.77 | ★ 62.73 |
| EPS | N/A | ★ 5.69 |
| Revenue | ★ $19,263,000,000.00 | $5,459,515,000.00 |
| Revenue This Year | $9.36 | $9.88 |
| Revenue Next Year | $15.43 | $6.32 |
| P/E Ratio | ★ N/A | $37.23 |
| Revenue Growth | 4.29 | ★ 6.24 |
| 52 Week Low | $22.28 | $195.14 |
| 52 Week High | $59.55 | $269.44 |
Technical Indicators
Market Signals| Indicator | MRNA | STE |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 47.59 |
| Support Level | $46.30 | $195.14 |
| Resistance Level | $55.36 | $227.10 |
| Average True Range (ATR) | 3.63 | 7.11 |
| MACD | 0.03 | 0.40 |
| Stochastic Oscillator | 30.44 | 79.58 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.